Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer

DOI Full Paper Access

13

Citations

21

References

2022

Year

Jang Ho Lee, Eun Young Kim, Cheol‐Kyu Park, Shin Yup Lee, Min Ki Lee, S.H. Yoon, Jeong Eun Lee, Sang Hoon Lee, Seung Joon Kim, Sung Yong Lee,

Cancer Research and Treatment

Abstract

Osimertinib demonstrated its clinical effectiveness and survival benefit for EGFR T790M mutation-positive in Korean patients with no new safety signals.

References

	Year	Citations

Page 1